A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumours

BACKGROUND: We previously reported that low-dose, short-course sunitinib prior to neoadjuvant doxorubicin-cyclophosphamide (AC) normalised tumour vasculature and improved perfusion, but resulted in neutropenia and delayed subsequent cycles in breast cancer patients. This study combined sunitinib wit...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:BMC Cancer
Hoofdauteurs: Ang, Yvonne L. E., Ho, Gwo Fuang, Soo, Ross A., Sundar, Raghav, Tan, Sing Huang, Yong, Wei Peng, Ow, Samuel G. W., Lim, Joline S. J., Chong, Wan Qin, Soe, Phyu Pyar, Tai, Bee Choo, Wang, Lingzhi, Goh, Boon Cher, Lee, Soo-Chin
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BioMed Central 2020
Onderwerpen:
Research Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7672922/
https://ncbi.nlm.nih.gov/pubmed/33203399
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-020-07616-4
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items